Vergoeding 2018-2022 voor ATC-subgroep J02AC : Triazool- en tetrazoolderivaten
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| J02AC01 Fluconazol (Diflucan ®) | 674.940 | 757.980 | 720.190 | 668.580 | 766.470 |
| J02AC02 Itraconazol (Trisporal ®) | 1.800.800 | 1.627.900 | 1.274.000 | 1.176.900 | 1.200.700 |
| J02AC03 Voriconazol (Vfend ®) | 800.370 | 655.340 | 560.110 | 430.040 | 337.430 |
| J02AC04 Posaconazol (Noxafil ®) | 6.118.500 | 6.751.400 | 5.074.100 | 3.304.100 | 3.734.300 |
| J02AC05 Isavuconazol (Cresemba ®) | 76.468 | 834.370 | 1.024.000 | 842.770 | 1.402.500 |
| Totaal | 9.471.078 | 10.626.990 | 8.652.400 | 6.422.390 | 7.441.400 |